Company intelligence / Profile preview

Aryballe Technologies

Ownership: Private
Development stage: Commercial

Overview

Aryballe has commercialized a patented digital olfaction platform that mimics the human sense of smell using silicon photonics and peptide-based sensors. Their products are used across industries—including automotive, food & beverage, consumer appliances, fragrances/cosmetics—for real-time odor/VOC analysis. The company’s solutions are deployed for R&D and quality control purposes rather than clinical trials or therapeutic outcomes.

Therapeutic areas: Other
Modalities: DeviceSensor
Industry: Non-Drug Biotech

Partnerships

Asahi KaseiJoint Development Agreements with various industrial partners for custom sensing solutions

Beyond the preview

Go deeper on Aryballe Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aryballe Technologies.

Explore the full profile